Top 5 Startups Providing Solutions During Coronavirus Pandemic Hit $433.2 Million in Total Funding

Jastra Ilic

Jastra is an editor, writer, and PR specialist with years of experience in the news, research, and report writing. Over the years, she has worked in different fields of journalism and public relations, including politics, economy, and financial markets.

Startups in coronavirus outbreak-AksjeBloggen.com

av Jastra Ilic Sist oppdatert: 10. august, 2020

Top 5 Startups Providing Solutions During Coronavirus Pandemic Hit $433.2 Million in Total Funding

The growing number of startups from all sectors and industries are offering their help and... Læs mere

av Jastra Ilic Sist oppdatert: 27. juli, 2020

Unicorns Raised $26.5bn Amid COVID-19 Outbreak

Recent years have witnessed a tenfold increase in the number of unicorns, rising from less... Læs mere

European Investment Bank-AksjeBloggen.com

av Jastra Ilic Sist oppdatert: 14. juli, 2020

European Investment Bank Financed €1.2trn of Projects Over Last Two Decades

As one of the world’s largest public lending institutions the European Investment Bank has granted... Læs mere

Pharma companies market cap-AksjeBloggen.com

av Jastra Ilic Sist oppdatert: 12. august, 2020

Market Cap of the Leading Pharma Companies Involved in COVID-19 Research Jumped by $51.1bn in Six Months

Farmasøytiske selskaper som tar sentrum i COVID-19-kampen, har vært vitne til en betydelig vekst i... Læs mere

av Jastra Ilic Sist oppdatert: 12. august, 2020

Top Five Initial Coin Offerings Hit $7.7bn in Total Funding

De siste årene har vi vært vitne til en imponerende vekst i det globale cryptocurrency-markedet,... Læs mere

Indlæs flere artikler ›

Note that the content on this site should not be considered investment advice. Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site.